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Summary: An effective and reliable method for the quantitative estimation of creatine kinase-MB, creatine
kinase-MM variants and mitochondrial forms of creatine kinase in serum is presented.
The high resölving power of isoelectric focusing allows the use of tetrazolium salts and meldola blue for the
quantitative measfurement without interfering non-specific reduction.
The addition of thiol compounds to the agarose medium increases the sensitivity of the method, due to the
Inhibition of stilfhydryl group oxidation, and prevents enzyme degradation, which is a possible cause of an
artificial heterogeneity.
Depending upon the type of muscle and the degree of cell damage, we found 3—4 creatine kinase-MM sub-
bands in sera with äctivities below 80 U/l. At elevated creatine kinase activities 3 — 11 creatine kinase-MM
sub^-bands were found. The appearance of creatine kinase-MB in serum indicates that damage has occurred
to certain organs, especially the cardiac muscle. An organ with moderate or massive cell damage could
release, in addition to the sarcoplasmatic creatine kinase variants, other forms with more alkaline isoelectric
points (mitochondrial creatine.kinase). The presence of such bands in serum of patients correlates with poor
prognosis.
Besides the Separation of creatine kinase-MM sub-bands, creatine kinase-MB, creatine kinase-BB and of
macrofonns l and 2, the advantage of this method is the detection of mitochondrial creatine kinase forms,
which in cellulose acetate electrophoresis migrate with creatine kinase-MM.
!) I: this j. 24, 283-292 (1986).
J. Clin. Chem. Clin. Biochem. / Vol. 24,1986 / No. 11
848 SiragEldin et al.: Heterogeneity of creatine kinase in human serura
Isoelekfrische Fokussierung von Kreatinkinase-Varianten:
U. Die Heterogenität (kr Kreatinkinase im menschlichen Serum mit normalen und erhöhten katalytischen
Konzentrationen
Zusammenfassung: Es wird eine effektive und zuverlässige Methode für die quantitative Bestimmung von
Kreatinkinase-MB, Kreatinkinase-MM-Varianten und mitochondrialen Formen der Kreatinkinase im Blut
vorgestellt. Das hohe Auflösungsvermögen der isoelektrischen Fokussierung für die Trennung und Konzentrie-
rung von Kreatinkinase-Varianten an ihren isoelektrischen Punkten ermöglicht die Anwendung von Tetrazoli-
umsalzen und Meldolablau zur quantitativen Messung ohne interferierende unspezifische Reduktion. Der
Zusatz von Thiolverbindungen zum Agarosemedium erhöht die Empfindlichkeit der Methode durch Schutz
der Sulfhydrylgruppen vor Oxidation und verhindert somit eine Enzyminaktivierung und eine daraus mögli-
cherweise resultierende künstliche Heterogenität.
In Relation zum Muskeltyp und der Schwere der Zellschädigung fanden wir 3-4 Kreatinkinase-MM-
Unterbanden in Seren mit Aktivitäten unter 80 U/l. Bei erhöhten Kreatinkinase-Aktivitäten waren 3-11
Kreatinkinase-MM-Unterbanden nachweisbar. Das Auftreten von Kreatinkinase-MB im Serum spiegelt die
Schädigung bestimmter Organe, insbesondere die des Herzmuskels wider.
Ein Organ mit mäßigem oder massivem Zellzerfall kann zusätzlich zu den sarkoplasmatischen Kreatinkinase-
Varianten andere Formen mit alkalischeren isoelektrischen Punkten (mitochondriale Kreatinkinasen) freiset-
zen. Das Auftreten solcher Banden im Serum von Patienten ist ein ungünstiges prognostisches Zeichen.
Der Vorteil des Verfahrens ist außer in der Trennung von Kreatiükinase-MM-Unterbanden, Kreatinkinase-
MB und den Makroformen l und 2 im Nachweis von mitochondrialen Kreatinkinasen zu sehen, die in der
Cellulose-Acetat-Folien-Elektrophorese eine ähnliche Mobilität wie Kreatinkinase-MM aufweisen.
Introduction
As the determination of the isoenzyme creatine ki-
nase-MB in human serum is the most sensitive indica-
tor for acute myocardial infarction (l, 2), an array
of methods have been published for its estimation
(3 — 8). Recently, using various methods, different
creatine kinase variants were observed in human
serum. The presence of such creatine kinase variants
may interfere in these tests, leading to erroneous
diagnosis of myocardial infarction (9 — 11). Further-
more, the existence of certain creatine kinase variants,
which upon electrophoresis migrate cathodally, anod-
ally or with creatine kinase-MM, have been shown
to correlate with poor prognosis in patients with
metastatic tumours or who are otherwise seriously ill
(12-16).
Recently, several authors have reported the existence
of creatine kinase-MM sub-bands in human serum,
but there is a lack of agreement on the number of
sub-bands. Some authors have reported three (17),
four (18) or five (19) creatine kinase-MM sub-bands
in human blood.
In a previous publication (20) we described our find-
ings on the heterogeneity of creatine kinase in human
heart cytosol and mitochondria. The studies indicated
considerable differences among these fractions in
their isoelectric points, electrophoretic behaviour and
response to immunoinhibition.
In the present study we have used isoelectric focusing
(IEF). This new approach is superior to the afore-
mentioned techniques, since it shows comparatively
high resolution of multiple forms, high specificity and
high sensitivity. In this study, the results obtained by
isoelectric focusing, the immunoinhibition test and
cellulose acetate electrophoresis are compared.
Evidence is presented that creatine kinase, in sera
with normal or elevated activities, exists in many
forms corresponding to those present in tissue ex-
tracts.
Materials and Methods
Materials
Dithiothreitol and CPK-Isotrol were obtained from Sigma Che-
mie, München. Creatine kinase NAC-activated and creatine
kinase-MB NAC-activated test kits were from Boehringer
Mannheim. 5.5-Diethylbarbituric acid and magnesium acetate
were purchased from Merck, Darmstadt. Cellulose. acetate
Strips (Sartorius membrane filter type SMN 11200 BD 5.7
4.5 cm) were obtained from Beckman, München. Ampholine
pH 3.5-9.5 Cat. No. 1818-101 and Ampholine pH 5-8 Cat.
No. 1818-126 were obtained from LKB, Bromma.
Methods
Quantitative determination of creatine kinase activities
The optimized spectrophotometric method based on the recom-
mendations of the German Society for Clinical Chemistry (21)
was üsed to measure total creatine kinase activity with a Hitachi
Rate Analyser at 25 °C.
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Creatine kinase-MB was determined at 25 °C after immunologi-
cal Inhibition of creatine kinase-M subunits by specific anti-
M-antibodies.
Cellulose acetate electrophoresis
Cellulose acetate electrophoresis was performed in a Boskamp
microphor chamber with a running buffer of 73 mmol/1 tris-
base and 24 mmol/1 barbituric acid supplemented with l mmol/1
dithiothreitol, pH at 8.6, for 35 min at 300 volts and 6—8 °C.
A creatine kinase control (CPK-ISOTROL) was used s a
marker. A detailed description of the method has been pub-
lished eisewhere (10).
We applied 2 to 3 μΐ^ sample either untreated or preincubated
with anti-creatine kinase-M, s published previously (22), with
slight modification. Briefly, 100 μΐ of sample were mixed for
one minute with 5 μΐ of anti-creatine kinase-M-an tibodies
(Merck No. 14326). The content of one vial was dissolved in
400 μΐ of test buffer instead of 2500 μΐ and incubated for 12
min at room temperature.
After electrophoresis, creatine kinase-isoenzyme bands were
visualized by placing the membrane on agar purum (Behring-
werke AG, Marburg) plates containing the reaction medium,
followed by incubation for 35 min at 37 °C.
Thin layer isoeleciric focusing of creatine kinase-isoenzymes on
Isogel agarose
For thin layer isoelectric focusing, we used a LKB modei 2217
Ultrophor. The procedures for the preparation of the thin layer
gel were s described by the manufacturer (23), except that the
followiug modifications were found necessary for an adequate
Separation of creatine kinase-isoenzymes:
a) Small wells were constructed using tesa film,
b) 2-mercaptoethanol at a final concentration of 2.5 mmol/1
was added to the agarose solution at 65 °C followed by the
Ampholine and
c) the gel was kept pvernight at 4—6 °C before use.
Isoelectric focusing was performed by applying 2—4 μΐ serum
to the pH 3.5—9.5 or pH 5 — 8 agarose gels.
measured s a percentage or fraction of the total creatine kinase
activity using the relative peak hcight of the creatine kinase-
MB band. When it was necessary to express creatine kinase-
MB s enzyme activity (U/l) the total creatine kinase activity
was multiplied by the percentage or fraction of creatine kinase-
MB.
Titration curve of creatine kinase-isoenzymes by 0.5 mm thin
layer isoeleciric focusing using Ampholine pH-ranges 3.5—9.5 or
5—8 in Isogel agarose
Preparation of the moul
A trench in the middle of the glass was constructed simply by
cutting two pieces of tesa film about 10cm long and 2mm
wide and then applying them to the middle of the glass plate
with a spacer (125 χ 240 mm). A second trench was constructed
in the same way and the glass plate was then left overnight to
dry.
The titration curve procedure
The gel was prepared s described previously.
\. First dimension isoelectric focusing. This was done without
adding the sample.
Voltage and current were set to maximum and the isoelectric
focusing was started by applying 500 volts with increasing the
power to about 6 W. The isoelectric focusing was performed
for 25 min for Ampholine pH 3.5 — 9.5 and 40 minutes for
Ampholine pH 5 —8. These conditions were sufficient to gener-
ate a stationary pH-gradient. A t this stage, the electrode Strips
were removed and the gel layers underneath were removed.
The pH-gradient formed was checked with a surface electrode
type 2117-222 (LKB).
2. The sample to be analysed (25 μΐ) was applied to the trench.
New electrodes were impregnated with an de and cathode
Solutions (23) and applied perpendicular to the first run. The
second dimension electrophoresis then was carried out for 12
min at 600 volts.
3. The detection of creatine kinase activity was performed
using the direct staining technique s described previously.
Detection of creatine kinase activity bands after thin layer isoelec-
tric focusing
The following reaction medium was prepared:
Solution A: One volume of 2% agar purum was heated to
boiling in distilled water and transferred to a water bath at
43 °C.
Solution B: One volume of the concentrated reaction medium
for the quantitative determination of creatine kinase (10) was
kept at 37 °C. Nitroblue tetrazolium (10 mg) and meldola
blue (0.5 mg) were added to 10ml of solution A and mixed
thproughly.
An equal volume of solution B was mixed with solution A,
poured onto the thin layer gel and Incubated for 35 min at
37 °C in the dark. The zymogram was then removed and
transferred to 10% acetic acid. To dry the agarose film, a thick
filter paper was carefully layered on the top of the gel followed
by a glass plate and a weight of about l kg. After 10 min, the
filter was removed and the gel was dried with a stream of cold
air. The formazane bands at the sites of creatine kinase activity
were traced with a Beckman model CDS-200 densitometer at
520 nm.
Creatine k;mase-MB activity is either expressed s absolute
activity (U/i) or s a percentage or fraction of the total creatine
kinase activity. With the IEF method, creatine kinase-MB was
Results
Detection limit and linearity
For the detection limit and linearity of the IEF, serial
dilutions from the serum of a patient with a proven
myocardial infarction were examined using human
serum with no detectable creatine kinase activity s
diluent.
The series covered the r nge of 116-928 U/l and
8 — 64 U/l of total creatine kinase and creatine kinase-
MB, respectively. Three microliters of each dilution
were applied to the IEF gel.
Figure l a shows that the method is linear up to 700
U/l of total creatine kinase. The lowest creatine ki-
nase value that could be distinguished from zero was
6 U/l. When IEF is compared with the immunoinhibi-
tion test within the above mentioned r nge, a correla-
tion coefficient of 0.992 (n = 7) is found.
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Fig. l a. Linearity of the IEF method (o-o) for the measure-
ment of total creatine kinase (minus creatine kinase-
MB) activities compared with spectrophotometric B
methods (O-o).
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Fig. l b. Number of creatine kinase-MM sub-bands obtained
by isoelectric focusing in the pH-range 3.5-9.5 in
relation to the applied amount of total creatine kinase
activity. The sera were obtained from a patient (a)
who had undergone myocardial surgery (944 U/l total
creatine kinase, 13 U/l creatine kinase-MB) and a
patient (b) with proven myocardial infarction (2097
U/l total creatine kinase, 193 U/l creatine kinase-MB).
Fig. l c. Number of creatine kinase-MM sub-bands by isoelec-
tric focusing in the pH-range 5^8 in relation to the
applied amount of total creatine kinase activity. The
sera applied were the same s described in flg. l b.
The number of creatine kin se-MM sub-bands was
not related to the applied total creatine kinase activity
(fig. l b) but to the pH-range used (fig. l c). To prove
that the bands obtained were true creatine. kinase-
MM sub-bands, sera were treated with anti-creatine
kinase-M-antibodies before isoelectric focusing. After
this treatment the bands disappeared in the pH-range
3.5-9.5 s well s in the pH-range 5-8 (fig. Ib
and l c).
..?
Within-run-precision
We evaluated the within-run-precision by m king
multiple applications to IEF gels of a serum sample
» ?
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obtained from a patient with proven myocardial in-
farction. All patterns were scanned äs described in
"methods".
The creatine kinase-MB activities äs estiinated by
both the immunoinhibition test and IEF are summar-
ized in table l.
The CVs were 1.5% for total creatine kinase, 6% for
immunologically measured creatine kinase-MB and
7% for creatine kinase-MB determined by IEF.
Tab. 1. Within-run-preäsion of the immunoinhibition test and
IEF.
Continuous methods
Total creatine "Creatine
kinase kinase-MB"
(U/l) (U/l)
X
SD
CV (%)
n
519
7.6
1.5
9
33
1.9
6
9
Isoelectric
focusing
Creatine
kinase-MB
(U/l)
34
2.5
7
9
n = number of assays, = mean value, SD = Standard
deviation, CV = coefficient of Variation.
"Creatine kinase-MB" = immunoinhibition test.
Between-ruii-precision
Aliquots of frozen (—20 °C) serum obtained from
a patient with proven myocardial infarction were
analysed by both the kinetic methods and IEF.
The data for the precision of the lEF-Isogel method
from day-to-day äs compared to the immunoinhibi-
tion test are shpwn in table 2. The CVs were 3.1%
for total creatine kinase and 11% for immunological
creatiiie kinase-MB. Using the IEF method the CV
for creatine kinase-MB was 10%, compared with CVs
of 7.8%, 3.2%, 4.8% and 10% for the creatine ki^
nase-MM sub-bands 1—4, respectively.
The transfer of creatine kinase-MM and
creatine kinase-MB, separated by cellulose
acetate electrophoresis, to thin layer iso-
electric focusing gels
Three sera, two from patients suffering from proven
myocardial infarction and one from a muscle trauma
patient, were separated by cellulose acetate electro-
phoresis äs described above. Figure 2 a demonstrates
the patterns obtained by cellulose acetate electropho-
resis. The sera of both patients suffering from my-
ocardial infarction showed creatine kinase-MM and
creatine kinase-MB bands, while the patient with
muscle trauma exhibited only a creatine kinase-MM
band in his serum. The unstained creatine kinase
bands corresponding to creatine kinase-MM and
creatine kinase-MB were cut out and layered carefully
onto the surface of the thin layer isoelectric focusing
gel. The corresponding serum samples (3—4 ) were
also loaded onto the thin layer gel. All samples were
focused and stained äs described in "methods".
Figure 2b demonstrates the patterns obtained äs a
result of the transfer of the cellulose acetate Strips to
the isoelectric focusing gel. The creatine kinase-MM
bands obtained after electrophoresis showed a hetero-
geneity ranging from 4 to 5 sub-bands similar to those
obtained by direct analysis of the sera by isoelectric
focusing. To prove that the above bands were really
creatine kinase-MM, the serum was incubated with
anti-creatine kinase-M-antibodies. After IEF no sub-
bands were seen. The creatine kinase-MB separated
by electrophoresis reveals only one band in the pH-
range 3.5—9.5 when IEF was used.
Figure 3 depicts two titration curves from a serum
of a patient with proven myocardial infarction, using
Ampholine pH 3.5-9.5 (a) and Ampholine pH 5-
8 (b) in Isogel agarose. Both curves show clearly that
the creatine kinase-MM isoenzyme was split into sub-
bands with different isoelectric points. The creatine
kinase-MB isoenzyme was focused at pH 5.5.
Tab. 2. Between-run-precision of the immunoinhibition test and IEF.
Contiiiuöus methods
SD
CV(%)
n
(U/l)
Total
creatine kinase
293
9
3.1
10
"Creatine
kinase-MB"
27
3
11
10
Isoelectric focusing
(U/l)
MM1
53
4
7.8
10
MM 2
87
2.8
3.2
10
MM 3
109
5.2
4.8
10
MM 4
15
1.6
10
10
Creatine
kinase-MB
29
2.9
10
10
n = number of assays, = mean value, SD = Standard deviation, CV
immunoinhibition test.
coefilcient of Variation, "creatine kinase-MBv
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Fig 2. Migration patteras of creatine kinase isoenzymes from patients with myocardial infarction (a, b) and muscle trauma (c).
C = CPK Isotrol. a) Electrophoresis on cellulose acetate Strips at pH 8.6. b) Isoelectric focusing in the pH-range 3.5-
9.5. The samples a, b, and c were separated by cellulose acetate electrophoresis and the bands containing creatine kinase-
MB and creatine kinase-MM isoenzymes were cut out, transferred to Isogel agarose and subjected to isoelectric focusing.
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Fig. 3. Titration curves on Isogel agarose in the pH-range 3.5 — 9.5 (a) and 5 — 8 (b). The serum was obtained frpm a patient
with proven myocardial infarction with 1070 U/l and 107 U/l for total creatine kinase and creatine kinase-MB, respectively.
The creatine kinase bands were visualised with meldola blue and nitroblue tetrazoliuna, using an overlay technique.
Investigations of sera from different groups
of patients
We selected patients with normal and elevated cre-
atine kinase activities without myocardial affections
and patients with proven myocardial infarction and
myocardial surgery. All specimens with a total crea-
tine kinase activity of more than 700 U/l were dihited
with saline before isoelectric focusing.
Figure 4 represents the means of different creatine
kinase-MM sub-band activities from patients with
normal and elevated creatine kinase. The creatine
kinase-MM sub-bands were obtained using an Am-
pholine pH 3.5 — 9.5 gradient in Isogel agarose. It
can be observed from figure 4 that creatine kinase-
MM sub-bands are present in sera of patients with
normal creatine kinase activity (—80 U/l) s well s
in those with elevated creatine kinase activities. In
the last group, however, a distinct creatine kinase-
MM sub-band 5 could be seen.
Figure 5 shows the frequency distribution of creatine
kinase-MM sub-bands in the two groups mentioned
above. The x-axis represents the percentage activity
of creatine kinase-MM sub-bands frorii total creatine
kinase, while the absolute frequency is scaled on
the y-axis. Each block represents one patient. The
distribution of the creatine kinase-MM sub-bands
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fluctuates within the same group. No creatine kinase-
MB band was observed in patients with normal cre-
atine kinase activity. In sorne patients with elevated
total creatine kinase activity, the presence of creatine
kinase-MB was shown with the immunoinhibition
test and IEF, but it did not exceed 4% of the total
creatine kinase activity. A good correlation between
the two methods (r = 0.987) was found.
In the sera of 50 myocardial infarction patients, va-
lues of 99 to 2213 U/l were found for total creatine
kinase. Values of 10 to 214 U/l and 13 to 171 U/l for
creatine kinase-MB were found with IEF and the
immunoinhibition test, respectively. Twenty three of
these were also analysed with cellulose acetate electro-
phoresis in order to compare the method with IEF
(table 3). A satisfactory correlation (r = 0.87) was
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Tab 3 Creatine kinase activities in sera of paüents with proven myocardial infarction measured by the immunoinhibition test
rSeaünc kinase-MB"), cellulose acetate electrophoresis and isoelectric focusmg on Isogel agarose.
Continuous methods Cellulose acetate Isoelectric focusing
— electrophoresis
Nr.
11
7t*
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Total
creatine
kinase
(U/l)
301
405
294
391
691
371
1723
1432
436
1178
2136
1524
790
735
718
1122
684
425'
451
415
349
345
1281
"Creatine
kinase-MB"
(%)
15
23
11
9
10
18
8
9
16
7
8
8
9
11
10
9
10
12
12
6
16
13
6
Creatine
kinase-MM
(%)
81
72
89
89
88
78
86
88
86
93
89
89
91
91
90
87
86
84
86
91
74
87
89
Creatine
kinase-MB
(%)
19
28
11
11
12
22
14
12
14
7
11
11
9
9
10
13
14
16
14
9
26
13
11
Creatine
kinase-MB
(%)
19
27
6
7
9
24
12
13
13
11
10
10
6
8
12
10
10
11
9
10
23
22
11
MM1
(%)
33
23
11
32
25
25
29
25
13
23
33
28
16
24
21
26
41
28
26
26
18
25
10
MM2
(%)
32
28
23
34
31
27
32
29
23
29
31
31
30
31
22
31
32
31
32
32
28
29
31
MM3
, r
(%)
16
18
34
20
24
22
24
25
38
28
21
26
36
2?
34
26
17
22
27
27
23
22
29
MM4
(%)
—4
17
7
8
2
3
8
8
9
5
5
12
8
11
7
—
8
6
3
5
2
19
MM5
(%)
-
—
9
—
3
—
—
—
5
•^
—
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—
—
-!-
—2
3
—
—
"Creatine kinase-MB" = immunoinhibition test.
found between cellulose acetate electrophoresis and
the IEF method. This is also true for the immunoinhi-
bition test and IEF (r = 0.85).
The mean activities obtained for creatine kinase-MM
sub-bands and creatine kinase-MB are demonstrated
in figure 6 a. Between 3 and 5 creatine kinase-MM
sub-bands were detected by using Ampholine pH
3.5-9.5.
This is also the case for sera from patients undergoing
cardiosurgery. In this group we observed a creatine
kinase-MB band, in addition to the 3 — 5 creatine
kinase-MM sub-bands (fig. 6b).
The Standard deviation of creatine kinase-MB in
patients with myocardial infarction is larger than
that observed in cardiosurgery patients (fig. 7). The
distribution of creatine kinase-MM sub-bands in
both groups is very different. The creatine kinase-
MB activity in patients with myocardial infarction
was more than 6% of the total creatine kinase activ-
ity. In cardiosurgery patients, creatine kinase-MB
values below or above 6% were observed.
The creatine kinase patterns shown in figure 8 were
found in four samples from different patients. Sam-
ple c was drawn from a patient with muscular trauma
and sample d from a patient undergoing myocardial
surgery. Samples a and b, which contained total cre-
atine kinase activities of 58 U/l and 60 Ü/l respec-
tively, showed 3 creatine kinase-MM sub-bands in
IEF. 11 Creatine kinase-MM sub-bands were detected
in samples c and d, which contained 1083 U/l or
1168 U/l total creatine kinase and 20 U/l or 108
U/l creatine kinase-MB, respectively. A correlation
between the immunoinhibition test and both the cel-
lulose acetate and IEF methods was not observed in
patients with falsely elevated immunological "creatine
kinase-MB" values (table 4).
In 10 out of 12 sera the creatine kinase-MB activity,
äs measured by the immunoinhibition test, was found
to be between 6—30% of the total creatine kinase-
activity. In contrast, no creatine kinase-MB band was
observed by either cellulose acetate electrophoresis
or IEF. Five out of 12 patients were suffering from
coronary heart diseases and had undergone surgical
operations. In the 3 patients suffering from myocar-
dial infarction, the samples were taken'in the late
phase of the infarction.
The serum with the high creatine kinase-MB activity
(42 U/l = 30%) was obtained from a patient after
laryngeectomy. Nine out öf 12 sera showed a high
• »
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Fig. 8. Creatine kinase variant patterns s revealed by IEF on
Proportion of the creatine kinase-MM 3 sub-band
(38 — 63%) s shown by IEF. The samples were kept
for 24 hours at —20 °C, and the immunological cre-
atine kinase-MB test was repeated. Creatine kinase-
MB activity was then not detectable in the patients
marked with an asterisk in table 4.
The appearance of unusal creatine kinase
bands in four patients
1. The first patient (I) was suffering from coronary
heart disease and had undergone an aortic valve
replacement Operation. Using cellulose acetate elec-i Jf  t , u m n i ci ic t
Isogel agarose using Ampholine pH 5-8. The samples trophoresis, no creatine kinase band migrating
were obtained from 4 different patients. For details see ^^ ^  ^ ^ χη^_ΜΜ was obseryed in
ca-
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serum. In contrast, isoelectric focusing demonstrated
two bands focusing cathodally to creatine kinase-
MM sub-barid l in the sera of this patient (flg. 9).
The appearance of these bands in addition to creatine
kinase-MM sub-bands and creatine kinase-MB was
noticed after reoperation occasioned by severe com-
plications. Following the postoperative course, the
bands were observed on fiVe consecutive days (tab. 5).
2. The second patient (II) had a transmural infarc-
tion. He was admitted to the intensive care unit
because of the onset of retrosternal pain. Total serum
activities were not elevated upon admissipn.
During the first 24 hours a maximum of total creatine
kinase (1469 U/l) and creatine kinase-MB (176 U/i)
activities was detectable (tab. 5). In addition to crea-
tine kinase-MM sub-bands and creatine kinase-MB,
two bands focusing cathodally to the creatine kinase-
MM subband l were obserVed in the following 24
hours at the maximum of total creatine kinase and
creatine kinase-MB activities (fig. 10, samples a
and b).
Five days later the patient suffefed a posterior wall
reinfarctiqn with cardiogenic shock and died. It is
worth noting that after treatment of these sera with
anti-creatine kinase-M polyclonal antibodies before
IEF, all creatine kinase-MM sub-bands s well s the
two additional bands completely disappeared. For
comparison, sample c (fig. 10) exhibits a creatine ki-
nase variant pattern typical for patients with myocar-
dial infarction.
3.5 i
pH
9.5
Cre tine
kinase
MB
3
 MM
sub-bands
Mi'Mi;! ?
MiMf II ?
Fig. 9. Separation of creatine kinase isoenzymes by isoeleetric
focusing in the pH-range 3.5-9.5. The samples a, b
and c were taken on three consecutive days ffoni a
patient sufFered fr m c ronary heart disease following
an aorting valve replacement.
l!
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Fig. 10. Migration of creatine kinase variants in IEF using
.
to
0
1 3·
Ampholine pH 3.5-9.5 in Isogel agarose. Samples a
and b were obtained from a patient with transmural
infarction. Sample c was obtained from another
patient with myocardial infarction.
In the serum from a patient (III) with Wolff-
'•g Parkinson- White syndrome, a total creatine kinase
'g activity of 199 U/l and a creatine kinase-MB of 294
S U/l were measured. The creatine kinase isoenzyme
·- patterns obtained by cellulose acetate electrophoresis
,
11
 are shown in figure 1 1 a. Three creatine kinase-isoen-
S2 zyme bands, i.e. creatine kinase-MM (17%), a band
ώ migrating between creatine kinase-MM and creatine
| kinase-MB (26%) and creatine kinase-MB (57%)
g were observed. The zymogram obtained by IEF (fig.
"| 1 1 b) reveals 3 creatine kinase-MM sub-bands, a
£ minor band focused above the creatine kinase-MM
•g subbands and a major one corresponding to creatine
Ix kinase-MB.
00
1 4* The serum of another patient (IV), suffering fromg a metastatic carcinoma of the rectum, revealed two
2 creatine kinase bands upon electrophoresis, one mi-
£ grating similarly to creatine kinase-MM and the other
j cathodally to it (fig. 12 a). The apiplication of the
'S same sample to IEF on Isogel revealed 3 bands with
„ more alkaline isoelectric points than those observed
* in the serum of patient I (fig. 12b). No creatine kin-
§ ase-MM sub-bands were observed. The treatment of
o
^ this serum with anti-creatine kinase-M before IEF
2 did not reduce the intensity of the bands.
1
(Λ
.§ Discussion
&t> Although isoelectric focusing has been used success-
^ fully to isolate, purify and characterize isoenzymes
" (24—26), this technique has not so far been used for
£ routine determination of creatine kinase-isoenzymes.
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Fig. 11. Migration patterns of creatine kinase variants frora a patient with Wolff-Parkinson-White syndrome: a) electrophoresis
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Fig. 12. Separation of creatine kinase isoenzyraes from a
patient with metastatic rectum carcinoma.
a) Cellulose acetate electrophoresis, b) IEF on Isogel
agarose using the pH-range 3.5-9.5.
a = sample obtained from a patient with coronary
heart disease (sample c from flg. 9).
b = sample obtained from a patient with metastatic
rectum carcinoma.
C = CPK Isotrol.
The present study was undertaken to develop a sensi-
tive and specific assay for the quantitative detection
of isoenzymes, based on physical properties of the
enzyme molecule s well s on enzyme activity. Due
to the high concentration of creatine kinase-isoen-
zymes at their isoelectric points, tetrazolium salts
may be used to give intense, clear bands with a
satisfactorily low background. Apart from providing
a quantitative detection of creatine kinase-MB, this
method yields better Information about the hetero-
geneity of cytosolic and mitochondrial creatine kinase
in both tissue extracts and human serum.
This method detected no adenylate kinase activity in
human sera, when creatine phosphate was omitted
from the reaction medium. Furthermore, the creatine
kinase-MM and creatine kinase-MB bands from cel-
lulose acetate electrophoresis are resolved by isoelec-
tric focusing on Isogel into 4—5 creatine kinase-MM
sub-bands and one creatine kinase-MB band using
an Ampholine of pH 3.5 — 9.5. Additional evidence
for the specificity of this method is seen in figure 2.
Comparison of creatine kinase-MB isoenzyme levels
by isoelectric focusing, the immunoinhibition test and
cellulose acetate electrophoresis in patients with prov-
en myocardial infarction showed a high correlation.
The increase of the average concentration of the MB-
isoenzyme found in this group is in agreement with
previous findings (10, 27).
In addition, the results obtained with IEF and the
immunoinhibition test in patients with recent cardiac
surgery, showed a high correlation and are cpmpar-
able with previous results (28).
A similar high correlation between the immunoinhibi-
tion test and IEF (r = 0.987) was observed in patients
* t
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without myocardial affections. Surprisingly increased
ereatine kinase-MB activities (above 6%) were found
in two patients. One of these patients was suffering
from polymyositis. The serum exhibited an additional
band between the creatine kinase-MM sub-bands and
creatine kinase-MB. Whether this fmding is of diag-
nostic value, has to be clarified. The occurrence of a
creatine kinase-MB band in polymyositis has been
described (27).
In the serum of the second patient III with Wolff-
Parkinson-White syndrome, similar results were ob-
tained by both cellulose acetate electrophoresis and
IEF. The quantitative distribution of creatine kinase-
MM (17%), the band migrating between creatine
kinase-MM and creatine kinase-MB (26%) and crea-
tine kinase-MB (57%) was determined by cellulose
acetate electrophoresis (fig. 1l a).
In the serum of another patient with a malignancy, we
found increased creatine kinase-BB and low creatine
kinase-MB activities upon cellulose acetate electro-
phoresis (16). By analysing this serum by IEF on
Isogel using pH 3.5 — 9.5, we noticed that the creatine
kinase-BB focused almost in the same position äs
creatine kinase-MB (20). Although the frequency of
creatine kinase-BB interference is in the Order of
1% (29), its presence with creatine kinase-MM may
reduce the specificity of the IEF method for the
diagnosis of myocardial infarction.
When examining patients' sera (tab. 4) a considerable
discrepancy was apparent between IEF and the im-
munoinhibition test. Above 6% creatine kinase-MB,
activity was detected by the immunoinhibition test,
whereas no creatine kinase-MB band was observed
by IEF or cellulose acetate electrophoresis.
The remarkable cliaracteristic of this finding is the
relatively high proportion of the creatine kinase-
MM 3 sub-band (38—63%) in nine out of 12 sera.
We observed also a high proportion of the creatine
kinase-MMl sub-band (46%) in the serum of two
patients of this grpüp. In addition, we noticed that
the apparent creatine kinase-MB in the sera of some
patients (tab. 4) of this group was not stable, since
storage of these sera for only 24 hours at -20°C
caused complete disappearance of creatine kinase-
MB activity according to the immunoinhibition test,
i.e. measurement on the next day was in complete
agreement with the results found by both cellulose
acetate electrophoresis and IEF. This phenomenon
was not observed in the serum of patients who had
undergone a laryngectomy. Concerning the hetero-
geneity .of creatine kinase-MM, some authors (17,
30—31) believe that the three creatine kinase-MM
and two creatine kinase-MB sub-bands are the result
of a postsynthetic Variation caused by a thermolabile
factor in serum, since only one type of creatine kin-
ase-MB and creatine kinase-MM is present in the
sarcoplasm of skeletal and heart muscle. Our results
show that the heterogeneity of creatine kinase-MM
can be detected at normal äs well äs at elevated
creatine kinase activities in human serum.
The application of serum with elevated creatine ki-
nase activity to Isogel agarose (pH 5 — 8) reveals 11
creatine kinase-MM sub-bands (fig. 8). Due to the
high sensitivity of the IEF, which allows the detection
of 3—4 creatine kinase-MM sub-bands even in sera
with low activity, we were now able to compare the
creatine kinase variant patterns in:
1. sera with normal activities,
2. sera with elevated (pathological) activities and
3. tissue extracts.
It is generally accepted that localized anoxia and
other factors, e. g. trauma, pain and extreme tempera-
ture, are the most prevalent causes of cell injury
leading to a loss of cell membrane integrity, which
results in' a release of cytoplasmic enzymes into the
circulation (31).
In contrast to several authors (32—33), our fmdings
in tissue studies confirm that creatine kinase exists in
many forms in heart muscle cells (20). We postulate
that, depending on the severity of the cell damage,
variable amounts of these different forms are released
into the serum. This was shown by our results, in
which many forms of creatine kinase corresponding
with those in tissue extracts were detectable in the
serum of several patients.
After release into the serum these forms are quickly
eliminated (fig. 9) and in part appear äs proteins with
lower isoelectric points (34).
Thus, in order to obtain representative and compar-
able results one should analyse the serum sample
immediately, or störe frozen.
Our results are not in agreement with those of others
who claim that creatine kinase-MM exists in only
one form and after release in the serum undergoes
postsynthetic transformation (17, 26, 32).
The creatine kinase-MiMi isoenzyme is distributed
widely in human tissue (15, 35), and its presence in
the sera of patients with malignancies or myocardial
infarction is associated with poor prognosis or high
mortälity (10-14, 16). In addition, diagnosis of peri-
operative myocardial injury is difficult (36), but find-
ings of unusual high postoperative creatine kinase-
isoenzyme activities can contribute to the diagnosis
(37).
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The potential advantage of the IEF method over
others is the ability to isolate, in addition to creatine
kinase-MM sub-bands and creatine kinase-MB, other
bands located cathodally to the creatine kinase-MM
sub-band 1. 1t is remarkable that the two bands in
the serum of patient I (fig. 9), who had a complicated
Operation, were observed in the postoperative phase.
The presence of these bands and the disappearance of
the creatine kinase-MB band in the late postoperative
phase may be explained by the different half life rates
of these proteins.
The presence of these bands in the serum of patient
II is also associated with poor prognosis (fig. 10).
The change in appearance of the various creatine
kinase-MM sub-bands suggests that such creatine
kinase-MM sub-bands are of particular diagnostic
and prognostic importance.
Further evidence for multiple forms of mitochondrial
creatine kinase is presented by the serurn from patient
IV. Although the electrophoresis resulted in two cre-
atine kinase bands, one migrating similar to creatine
kinase-MM and the other cathodally to it, no creatine
kinase-MM sub-bands were observed in IEF. In addi-
tion, we noticed 3 bands with more alkaline isoelectric
points than those observed in sera of patients with
myocardial injury (fig. 12).
The electrophoretic behaviour of the additional crea-
tine kinase forms noticed in patients I and II (fig. 9
and 10) and their reaction with anti-creatine kinase-
M polyclonal antibodies is comparable to multiple
forms of creatine kinase found in human cardiac
mitochondria (19). These Undings could explain why
other authors were unable to detect these forms (mU
tochondrial?) in the sera of patients with myocardial
infarction, using electrophoresis or the immunoinhi-
bition test (27, 38).
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